t
Phth-CH2), 3.83 (1H, d, J 17.0, CHaHbCO2 Bu), 4.78–4.88 (1H,
NCHaHbCO), 5.30 (1H, m, H4Ј), 6.78 (1H, br s, CH2CONH ),
m, H4Ј), 7.62–7.70 and 7.71–7.79 (each 2H, m, Ar), 7.81 (1H, s,
H6), 8.97 (1H, s, thymine NH); δC (67.9 MHz, CDCl3) 12.0
(thymine CH3), 28.1 (C(CH3)3), 37.0 (C3Ј), 39.0 (Phth-CH2),
52.4 (C4Ј), 54.0 (CH2CO2 Bu), 57.8 (C5Ј), 61.2 (C2Ј), 81.3
(C(CH3)3), 110.6 (C5), 123.3, 131.8 and 134.2 (3 × Ar), 137.9
7.48 (1H, d, J 1.5, H6); δC (75.5 MHz, CDCl3) 13.1 (thymine
CH3), 37.0 (C3Ј), 46.8 (NHCH2), 52.5 (C4Ј), 56.4 (NCH2), 59.1
(C2Ј), 60.3 (C5Ј), 112.7 (C5), 137.1 (C6), 151.4 (C2), 164.2 (C4),
169.5 (CH2CONH); m/z (FABϩ) 265 ([M ϩ H]ϩ, 100%), 176
(20); HRMS m/z (EI) 264.1225 (Mϩ, C12H16N4O3 requires m/z,
264.1222).
t
(C6), 150.9 (C2), 163.5 (C4), 168.4 (Phth CO) and 169.6
t
(CO2 Bu); m/z (FABϩ) 469 ([M ϩ H]ϩ, 25%), 413 (44), 314
(100), 254 (85); HRMS m/z (FABϩ) 469.2103 ([M ϩ H]ϩ,
C24H29N4O6 requires m/z, 469.2087).
T2-Boc-POM (27)
A solution of Phth-T2-Boc-POM 21 (83 mg, 0.116 mmol) in
40% aqueous methylamine (1 mL) was stirred at room temper-
ature for 40 min. Evaporation under reduced pressure then col-
umn chromatography (10 15% CH3OH in CH2Cl2with 0.5%
DIPEA) separated the desired amine 27 at lower Rf from the
intermediate product at higher Rf (assumed to be 29). The latter
29 was treated with 40% aqueous methylamine (1 mL) for a
further 30 min; evaporation and purification as before gave
H2N-T2-Boc-POM 27 as a white foam (combined yield of 51
mg, 75%). δH (300 MHz, CD3OD) 1.50 (9H, br s, C(CH3)3), 1.90
and 1.91 (each 3H, s, thymine CH3), 2.27–2.65 (4H, m), 2.73–
2.94 (2H, m), 2.94–3.18 (3H, m), 3.19–3.34 (1H, m), 3.44–3.79
(4H, m), 3.85–4.15 (2H, m), 4.63–4.82 and 4.96–5.11 (each 1H,
m, H4Ј), 7.48 and 7.83 (each 1H, s, H6); δC (75 MHz, CD3OD)
12.7 and 12.9 (2 × thymine CH3), 24.4 (C3Ј), 29.1 (C(CH3)3),
33.5, 36.3, 41.6, 43.5, 45.4, 54.4, 57.6, 57.8, 60.0, 64.2 (2 × C1Ј,
2 × C2Ј, C3Ј, 2 × C4Ј, 2 × C5Ј and NCH2CONH), 82.2 and
82.5 (C(CH3)3 rotamers), 112.0 and 112.4 (2 × C5), 140.1 and
140.4 (2 × C6), 153.2 and 153.3 (2 × C2), 166.8 and 166.8 (2 ×
C4), 174.2 (CH2CONH); m/z (FABϩ) 627 ([M ϩ K]ϩ, 3%), 511
(5), 345 (60); HRMS m/z (FABϩ) 627.2893 ([M ϩ K]ϩ,
C27H40N8O7K requires m/z, 627.2657).
N-Carboxymethyl-(2ЈR,4ЈR)-2Ј-[(phthalimido)methyl]-4Ј-
(thymin-1-yl)pyrrolidine trifluoroacetic acid salt (25). Tri-
fluoroacetic acid (0.5 mL) was added to a solution of tert-butyl
ester 24 (72 mg, 0.154 mmol) in dichloromethane (2.0 mL) and
the mixture was stirred for 3 h at room temperature. Evapor-
ation under reduced pressure followed by column chromato-
graphy (5 15% CH3OH in CH2Cl2) gave the acid 25 (81 mg,
100%) as a white foam. Rf 0.62 (20% CH3OH in CH2Cl2); [α]D
Ϫ9.0 (c = 0.5, CH3OH); δH (300 MHz, CD3OD) 1.90–2.10 (1H,
m, Ha3Ј), 2.42–2.55 (1H, m, Hb3Ј), 2.60–2.76 (1H, m, Ha5Ј),
2.93–3.15 (1H, m, H2Ј), 3.04 (1H, d, J 17.0, CHaHbCO2H),
3.50–3.60 (1H, m, Hb5Ј), 3.65–3.75 (1H, m, Phth-CHaHb), 3.85
(1H, dd, J 14.7, 4.9, Phth-CHaHb), 3.96 (1H, d, J 17.0, CHaHb-
CO2H), 4.48–4.57 (1H, m, H4Ј), 7.67 (4H, s, Ar), 7.95 (1H, s,
H6); δC (75.5 MHz, CD3OD) 12.5 (thymine CH3), 37.6 (C3Ј),
39.6 (Phth-CH2), 56.0 (CH2CO2H), 56.2 (C4Ј), 58.5 (C5Ј), 63.6
(C2Ј), 111.2 (C5), 117.0 (q, J 244.1, CF3), 124.6, 133.6 and
135.9 (Ar), 141.5 (C6), 153.4 (C2), 163.1 (q, J 88.6, CF3CO2),
166.6 (C4), 170.6 (Phth CO), 176.7 (CO2H); m/z (FABϩ) 545
([M ϩ Cs]ϩ, 6%), 435 ([M ϩ Na]ϩ, 10), 423 ([M ϩ H]ϩ, 24), 392
(20), 344 (100); HRMS m/z (FABϩ) 413.1443 ([M ϩ H]ϩ,
C20H21N4O6 requires m/z, 413.1461).
T2-POMؒ3HCl (30)
N-(Pentafluorophenoxycarbonyl)methyl-(2ЈR,4ЈR)-2Ј-
T2-Boc-POM 27 (51 mg, 0.087 mmol) was dissolved in a solu-
tion of 1 : 1 THF–CH3OH (1 mL) saturated with HCl gas.
After stirring for 15 minutes a white precipitate formed. The
mixture was then cooled to 0 ЊC for 10 min and filtered. The
filtrate was re-cooled to 0 ЊC and a second batch of precipitate
was collected. The combined precipitate was dried under
reduced presure to give T2-POM hydrochloride salt 30 (49 mg,
94%) as a white solid. δH (500 MHz, D2O) 1.88 (3H, s, thymine
CH3), 2.00 (3H, s, thymine* CH3), 2.19 (1H, ddd, J 14.0, 9.9,
6.2, H3Ј), 2.26 (1H, ddd, J 14.3, 11.5, 6.5, H*3Ј), 2.77 (1H, ddd,
J 14.3, 9.6, 7.4, H*3Љ), 2.93 (1H, ddd, J 14.0, 9.6, 7.4, H3Љ), 3.38
(1H, dd, J 13.6, 7.8, H6Ј), 3.47 (1H, dd, J 12.5, 8.8, H5Љ), 3.51
(2H, dd, J 13.6, 3.4, H6Љ), 3.70 (1H, dd, J 13.4, 7.8, H*5Љ), 3.79
(1H, d, J 16.1, H7Ј), 3.81 (1H, dd, J 13.4, 2.8, H*5Ј), 3.86 (2H,
dd, J 15.3, 4.1, H*6Ј and H*6Љ), 3.91 (1H, dd, J 12.5, 3.7, H5Ј),
3.93 (1H, dddd, J 11.1, 7.4, 41, 4.1, H*2Ј), 4.11 (1H, d, J 16.1,
H7Љ), 4.86 (1H, dddd, J 9.6, 7.8, 6.5, 2.8, H*4Ј), 5.03 (1H, dddd,
J 9.6, 8.8, 6.2, 3.7, H4Ј), 7.48 (1H, s, H*6), 7.61 (1H, s, H6).
*Denotes lower pyrrolidine ring (see ESI for numbering sys-
tem). δC (100.6 MHz, D2O) 11.6 and 11.7 (2 × thymine CH3),
31.6 and 33.4 (2 × C3Ј), 39.1 and 39.3 (2 × C5Ј), 49.5, 55.1, 59.3
(2 × C6Ј, NCH2CO), 57.1, 60.1, 60.8, 63.3 (2 × C2Ј, 2 × C4Ј),
110.8 and 111.5 (2 × C5), 142.1 and 143.5 (2 × C6), 152.3 and
152.7 (2 × C2), 166.8 and 167.0 (2 × C4), 171.5 (CH2CONH);
m/z (FABϩ) 511 ([M Ϫ 3HCl ϩ Na]ϩ, 98%), 489 ([M Ϫ 3HCl ϩ
H]ϩ, 100); HRMS m/z (FABϩ) 489.2565 ([M Ϫ 3HCl ϩ H]ϩ,
C22H33N8O5 requires m/z, 489.2574).
[(phthalimido)methyl]-4Ј-(thymin-1-yl)pyrrolidine (26). Dry
pyridine (5 µL, 0.063 mmol) and pentafluorophenyl tri-
fluoroacetate (6 µL, 0.035 mmol) were added to a solution of
acid 25 (15 mg, 0.029 mmol) in dry DMF (100 µL). The mixture
was stirred at room temperature for 2 h and then evaporated
under reduced pressure. Ethyl acetate (2 mL) and 5% aqueous
NaHCO3 (2 mL) were then added and the mixture was
extracted with ethyl acetate (5 × 1 mL). The extracts were dried
over anhydrous MgSO4, filtered, evaporated under reduced
pressure and then purified by column chromatography (ethyl
acetate) to give the ester 26 (13 mg, 78%) as a white foam.
δH (300 MHz, CDCl3) 1.17 (3H, s, thymine CH3), 1.88–1.99
(1H, m, Ha3Ј), 2.54–2.68 (1H, m, Hb3Ј), 2.77 (1H, dd, J 11.3,
6.8, Ha5Ј), 3.00–3.09 (1H, m, H2Ј), 3.30 (1H, d, J 10.9, Hb5Ј),
3.52 (1H, d, J 17.7, NCHaHbCO2), 3.80 (1H, dd, J 14.7, 1.9,
Phth-CHaHb), 3.90 (1H, dd, J 14.7, 4.5, Phth-CHaHb), 4.43
(1H, d, J 17.7, NCHaHbCO2), 4.83–4.92 (1H, m, H4Ј), 7.61
(1H, d, J 1.14, H6), 7.68 (2H, dd, J 5.6, 3.03, Ar), 7.77 (2H, dd,
J 5.5, 3.03, Ar), 7.95 (1H, s, thymine NH); δF (188.2 MHz,
CDCl3) Ϫ84.04 (2F, dd, J 21.8, 17.3, m-F), Ϫ79.47 (1F, t, J 21.8,
p-F), Ϫ74.45 (2F, d, J 17.3, o-F); m/z (FABϩ) 579 ([M ϩ H]ϩ,
100%), 292 (73); HRMS m/z (EI) 578.1217 (Mϩ, C26H19N4O6F5
requires m/z, 578.1225).
(7R,8aR)-7-(Thymin-1Ј-yl)hexahydropyrrolo[1,2-a]pyrazin-3-
one (28). A solution of Phth-T2-Boc-POM 21 (71 mg, 0.099
mmol) in 40% (w/v) aqueous methylamine (1 mL) was warmed
to 50 ЊC for 5 h. On cooling to room temperature the solution
was evaporated under reduced pressure and purified by column
chromatography (10 15% CH3OH in CH2Cl2) to give the
lactam 28 (18 mg, 69%) as a white foam. δH (300 MHz, CDCl3)
1.33–1.44 (1H, m, Ha3Ј), 1.89 (3H, d, J 1.1, thymine CH3), 2.40–
2.68 (3H, m, Hb3Ј, H2Ј and Ha5Ј), 2.86 (1H, d, J 16.2, NCHa-
HbCO), 3.03 (1H, d, J 11.3, Hb5Ј), 3.23 (1H, dd, J 10.6 and 10.9,
NHCHaHb), 3.38–3.47 (1H, m, NHCHaHb), 3.65 (1H, d, J 16.2,
Phth-T3-Boc-POM (32)
Phth-T2-Boc-POM 21 (370 mg, 0.515 mmol) was added to a
20% solution of CF3CO2H in CH2Cl2 (10 mL) and stirred at
room temperature for 4 h. The solvent was removed under a
stream of argon followed by evaporation under reduced pres-
sure. Dry DMF (2 mL), bromoacetamide 20 (229 mg, 0.515
mmol) and DIPEA (450 µL, 2.58 mmol) were then added and
O r g . B i o m o l . C h e m . , 2 0 0 3 , 1, 3 2 7 7 – 3 2 9 2
3289